Standard Standard

Guideline for the classification of the acute emetogenic potential of antineoplastic medication in pediatric cancer patients. / Dupuis, L.L.; Boodhan, S.; Sung, L. et al.
In: Default journal, 01.08.2011.

Research output: Contribution to journalArticlepeer-review

HarvardHarvard

Dupuis, LL, Boodhan, S, Sung, L, Portwine, C, Hain, R, McCarthy, P & Holdsworth, M 2011, 'Guideline for the classification of the acute emetogenic potential of antineoplastic medication in pediatric cancer patients', Default journal.

APA

Dupuis, L. L., Boodhan, S., Sung, L., Portwine, C., Hain, R., McCarthy, P., & Holdsworth, M. (2011). Guideline for the classification of the acute emetogenic potential of antineoplastic medication in pediatric cancer patients. Default journal.

CBE

Dupuis LL, Boodhan S, Sung L, Portwine C, Hain R, McCarthy P, Holdsworth M. 2011. Guideline for the classification of the acute emetogenic potential of antineoplastic medication in pediatric cancer patients. Default journal.

MLA

VancouverVancouver

Dupuis LL, Boodhan S, Sung L, Portwine C, Hain R, McCarthy P et al. Guideline for the classification of the acute emetogenic potential of antineoplastic medication in pediatric cancer patients. Default journal. 2011 Aug 1.

Author

RIS

TY - JOUR

T1 - Guideline for the classification of the acute emetogenic potential of antineoplastic medication in pediatric cancer patients

AU - Dupuis, L.L.

AU - Boodhan, S.

AU - Sung, L.

AU - Portwine, C.

AU - Hain, R.

AU - McCarthy, P.

AU - Holdsworth, M.

PY - 2011/8/1

Y1 - 2011/8/1

M3 - Article

JO - Default journal

JF - Default journal

ER -